# Anthrax AV7909 Liquid vs Lyophilized

> **NCT04660201** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 41 (actual)

## Conditions studied

- Anthrax
- Anthrax Immunisation

## Interventions

- **BIOLOGICAL:** AV7909
- **BIOLOGICAL:** AV7909

## Key facts

- **NCT ID:** NCT04660201
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-25
- **Primary completion:** 2023-11-01
- **Final completion:** 2024-03-30
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2024-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04660201

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04660201, "Anthrax AV7909 Liquid vs Lyophilized". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04660201. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*